A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors (clinicaltrials.gov) - Feb 2, 2024 - P1/2 | N=132 | Recruiting | Sponsor: Tasly Pharmaceutical Group Co., Ltd
New P1/2 trial • Endometrial Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Solid Tumor • Triple Negative Breast Cancer
|